Researchers evaluated the efficacy of cannabinoid-based therapies for managing agitation and neuropsychiatric symptoms in Alzheimer disease.

In the reward circuitry of the brain, α-7-nicotinic acetylcholine receptors (α7nAChRs) modulate effects of Δ 9-tetrahydrocannabinol (THC), marijuana's main psychoactive ingredient. Kynurenic acid ...

Trait Biosciences highlights CBD82S™ reducing anxiety-like behavior in mice, showcasing enhanced absorption via ...

When you're under stress, your brain may release its own cannabinoid molecules to calm you, activating the same brain receptors as THC derived from cannabis plants. But the brain activity regulated by ...

Sleep affects nearly every chronic condition healthcare wants to manage. here's why cannabinoids like CBN are emerging as healthcare's next evidence-based opportunity.

When we think cannabis, most of us think of the chemical THC — although CBD is quickly rising in popularity, too. Both cannabidiol and tetrahydrocannabinol, to give them their full names, are ...

The International Cannabinoid Research Society (ICRS) plays a vital role in advancing the understanding of cannabinoids, substances found in the cannabis plant that have been of significant interest ...

Total non-dilutive funding awarded to eXoZymes is now almost $20 million, validating the scalable nature of the ...

The company secured an exclusive global licensing agreement for CannEpil.